Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.
During the past four decades, methicillin-resistant Staphylococcus aureus, or MRSA, has evolved from a controllable nuisance into a serious public health concern. MRSA is largely a hospital-acquired infection, in fact, one of the most common. Recently, however, new strains have emerged in the community that are capable of causing severe infections in otherwise healthy people.
NIH Grantees Find Genes for Susceptibility to MRSA Bacteria in Mice
MRSA Proves a Stubborn Opponent in Labs and Locker Rooms
NIAID-Funded Researchers Discover An Additional Way that S. Aureus Evades Immune System Attacks
Media Availability: Researchers Launch Phase 1 Clinical Trial of Potential MRSA Treatment—Jan. 24, 2014
Media Availability: NIH-Supported Clinical Trial of Novel Staphylococcal Antibiotic Begins—Oct. 17, 2012
Media Availability: NIH Scientists Link Quickly Spreading Gene to Asian MRSA Epidemic—April 22, 2012
Media Availability: NIH-Supported Scientists Investigate a Newly Emerging Staph Strain—Feb. 28, 2012
News From NIAID-Supported Institutions
Last Updated January 24, 2014
Last Reviewed March 09, 2011